| ¿µ¹® | epinephrine | ÇÑ±Û | ¿¡Çdz×ÇÁ¸° |
|---|---|---|---|
| ¼³¸í | ÄáÆÏÀÇ À§¿¡ Á¸ÀçÇÏ´Â »ï°¢Çü¸ð¾çÀÇ ±â°üÀÎ ºÎ½ÅÀÇ ³»ºÎ¿¡ ÇØ´çÇÏ´Â ¼ÓÁú¿¡¼ ºÐºñµÇ´Â ¹°Áú, ¶ÇÇÑ ±³°¨½Å°æÀÇ ¸»´Ü¿¡¼µµ ºÐºñµÇ±âµµ ÇÑ´Ù. »ý¸®ÀûÀ¸·Î´Â ½ÉÀå¿¡ ÀÛ¿ëÇÏ¿© ½É¹Ú¼ö ¹× ½ÉÀå¿¡¼ ³»º¸³»´Â ÇÇÀÇ ¾çÀ» Áõ°¡½Ã۸ç Ç÷°üº®¿¡ Á÷Á¢ ÀÛ¿ëÇÏ¿© ¸¹Àº Ç÷°üÀ» ÇöÀúÇÏ°Ô ¼öÃà½ÃŰ³ª, ½ÉÀå°ú Ç÷°ü¿¡ ´ëÇÑ ÀÌ»ó°ú °°Àº ÀÛ¿ëÀÇ °á°ú·Î Ç÷¾ÐÀÌ »ó½ÂÇÑ´Ù. ÀÌ Ç÷¾Ð»ó½Â ÀÛ¿ëÀº ±Þ°ÝÇϰí Àϰú¼ºÀ̶ó´Â Á¡ÀÌ Æ¯Â¡ÀÌ´Ù. |
||
| ¿µ¹® | inhalation | ÇÑ±Û | ÈíÀÔ(¹ý) |
|---|---|---|---|
| ¼³¸í | 1. ÈíÀÔ. °ø±â³ª ¾î¶² ¹°ÁúÀ» Æó¼ÓÀ¸·Î »¡¾ÆµéÀÌ´Â °Í. 2. ¾à ¶Ç´Â ¾àÀÇ ¿ë¾×À» ºÐ¹«±â¸¦ ÀÌ¿ëÇϰųª ¿¬¹«ÁúÀÇ ÇüÅ·ΠÄÚ³ª ÀÔÀÇ È£ÈíÅë·Î¸¦ ÅëÇØ¼ Åõ¿©ÇÏ´Â ¹æ¹ý. |
||
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
|---|---|
| HIT | hemagglutination inhibition test; heparin-induced thrombocytopenia; histamine inhalation test; hyper... |
| INH | inhalation; isoniazid; isonicotinic acid hydrazide |
| inhal | inhalation |
| MICR | methacholine inhalation challenge response |
| MIC | Methacholine inhalation challenge |
|---|---|
| DI | deep inhalation |
| E | Epinephrine |
| EP | Epinephrine |
| EPI | Epinephrine |
| iodate reaction of epinephrine | A reaction dependent upon the oxidation of epinephrine by iodine liberated from iodate, which is decomposed by the hormone; a faint pink colour results. (05 Mar 2000) |
|---|---|
| iodine reaction of epinephrine | A reaction resulting from the oxidation of the hormone, a faint pink colour appearing upon the addition of iodine. (05 Mar 2000) |
| epinephrine | <drug> A cardiac drug used for cardiac arrest from ventricular fibrillation, ventricular tachycardia, asystole, or pulseless electrical activity; extreme hypotension; bradycardia and heart block. Pharmacologic action: 1. Beneficial mainly due to alpha stimulation - increases systemic vascular resistance and improves coronary and cerebral blood flow. 2. Value of beta stimulation is controversial - increases myocardial electrical activity and strength of contraction, but also increases myocardial oxygen requirements and automaticity. Dose: Cardiac arrest: Recommended: 1 mg IV push every 3-5 min Intermediate: 2-5 mg IV push every 3-5 min Escalating: 1 mg, 3 mg, 5 mg IV push 3 min apart High: 0.1 mg/kg IV push every 3-5 min Continuous infusion for bradycardia and severe hypotension: 2 - 10 mcg/min. Epinephrine can be delivered via the endotracheal tube. Increase dose 2-2.5 times IV dose. Potential complications: hypertension and tachycardia, arrhythmias, especially ventricular ectopy, myocardial ischemia. Synonym: adrenaline. (15 Mar 2000) |
| epinephrine cyclase | <enzyme> Epinephrine is converted to adrenochrome Registry number: EC 1.10.3.- Synonym: catecholamine cyclase (26 Jun 1999) |
| epinephrine reversal | The fall in blood pressure produced by epinephrine when given following blockage of alpha-adrenergic receptors by an appropriate drug such as phenoxybenzamine; the vasodilation reflects the ability of epinephrine to activate beta-adrenergic receptors which, in vascular smooth muscle, are inhibitory; in the absence of alpha-receptor blockade, the beta-receptor activation by epinephrine is masked by its predominant action on vascular alpha-receptors, which causes vasoconstriction. Synonym: adrenaline reversal. (05 Mar 2000) |
| ferric chloride reaction of epinephrine | An intense emerald green colour in a neutral or slightly acid solution of epinephrine when ferric chloride is added to it; a reaction typical of catechols. (05 Mar 2000) |
| administration, inhalation | The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. (12 Dec 1998) |
| anaesthesia, inhalation | Anaesthesia caused by the breathing of anaesthetic gases or vapors or by insufflating anaesthetic gases or vapors into the respiratory tract. (12 Dec 1998) |
| anaesthetics, inhalation | Gases or volatile liquids that vary in the rate at which they induce anaesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anaesthetics have advantages over intravenous agents in that the depth of anaesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (12 Dec 1998) |
| burns, inhalation | Burns of the respiratory tract caused by heat or inhaled chemicals. (12 Dec 1998) |
| smoke inhalation injury | Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients. (12 Dec 1998) |
| solvent inhalation | Inhalation of volatile organic solvents used in glue, nail polish remover, lacquer thinners, cleaning fluid, lighter fluid, and gasoline, for the purpose of self-intoxication. See: glue-sniffing. (05 Mar 2000) |
| inhalation | <physiology> The drawing of air or other substances into the lungs. Origin: L. Inhalatio (18 Nov 1997) |
| inhalation anaesthesia | General anaesthesia resulting from breathing of anaesthetic gases or vapors. (05 Mar 2000) |
| inhalation anaesthetic | A gas or a liquid with sufficient vapor pressure to produce general anaesthesia when breathed. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|